OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,904,424 | -75.3% | 235,176 | -82.0% | 0.48% | -70.7% |
Q2 2023 | $11,778,118 | +68.7% | 1,304,332 | -35.2% | 1.62% | +79.8% |
Q1 2023 | $6,981,130 | +40.7% | 2,011,853 | -0.7% | 0.90% | +18.4% |
Q4 2022 | $4,961,823 | +28.4% | 2,025,234 | +44.7% | 0.76% | -6.5% |
Q3 2022 | $3,863,000 | +281.0% | 1,399,633 | +461.6% | 0.81% | +214.3% |
Q2 2022 | $1,014,000 | -15.2% | 249,229 | -11.3% | 0.26% | -33.2% |
Q1 2022 | $1,196,000 | -56.5% | 280,827 | -4.4% | 0.39% | -73.6% |
Q4 2021 | $2,750,000 | – | 293,799 | – | 1.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |